Press-release for stocks published on this month for gild

Gilead Sciences Publishes 2023 ESG Impact Report
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
GILD | News | $66.16 -1.15% -1.16% 4.9M

| -0.04% | O: -0.04% H: 0.0% C: 0.0%
gilead report sciences impact esg

| -1.12% | O: -100.0% H: NaN% C: Infinity%
GILD | News | $66.16 -1.15% -1.16% 4.9M

| -1.79% | O: 0.5% H: 0.83% C: 0.28%
CTXR | $0.8055 -1.31% -2.02% 6.1M

| -11.81% | O: 2.33% H: 2.28% C: -4.23%
hope treatment pharmaceuticals city for car-t trial

Leap Therapeutics Announces $40 Million Private Placement
Published: 2024-04-11 (Crawled : 20:00) - biospace.com/
LPTX | $2.96 -1.33% -1.35% 100K

| -2.63% | O: 15.13% H: 25.43% C: -11.0%
GILD | News | $66.16 -1.15% -1.16% 4.9M

| -1.79% | O: 0.5% H: 0.83% C: 0.28%
million leap therapeutics

Gilead Sciences to Release First Quarter 2024 Financial Results on Thursday, April 25, 2024
Published: 2024-04-08 (Crawled : 23:00) - biospace.com/
GILD | News | $66.16 -1.15% -1.16% 4.9M

| -3.85% | O: -0.76% H: 0.72% C: 0.54%
gilead first sciences financial results

RedHill Biopharma Announces Full-Year 2023 Results and Operational Highlights
Published: 2024-04-08 (Crawled : 13:30) - prnewswire.com
RDHL | $0.4208 9.16% 10.37% 660K

| -26.28% | O: 0.57% H: 0.0% C: -1.5%
GILD | News | $66.16 -1.15% -1.16% 4.9M

| -3.85% | O: -0.76% H: 0.72% C: 0.54%
biopharma results

Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer
Published: 2024-04-02 (Crawled : 20:00) - globenewswire.com
RMD | $177.61 2.18% 0.01% 1.6M